OppenheimerFunds’s Affimed AFMD Stock Holding History

OppenheimerFunds’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,407	Closed	-$61K	–	1790
2018 Q3	$61K	Buy	+1,407	New	+$39.9K	﹤0.01%	1808

Other funds holding AFMD

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

OppenheimerFunds's AFMD Position: Q4 2018 in Review

OppenheimerFunds sold out of Affimed (AFMD) in Q4 2018, closing a stake of 1,407 shares — an estimated $61K sold.

OppenheimerFunds first reported a position in AFMD in Q3 2018 and held it in 1 quarter. The position peaked at $61K in Q3 2018. 51 funds tracked by Wall St. Rank hold AFMD as of Q4 2018.

OppenheimerFunds reported no remaining Affimed position as of Q4 2018 after selling out during the quarter.
OppenheimerFunds sold 1,407 Affimed shares in Q4 2018, an estimated $61K.
OppenheimerFunds first reported a position in Affimed in Q3 2018 and held it in 1 quarter.
OppenheimerFunds's Affimed position peaked at $61K in Q3 2018.
51 funds tracked by Wall St. Rank held Affimed as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.